BioSpace News Archive

Spherix Incorporated (Nasdaq: SPEX) today announced that it has added Dr. Rana Quraishi to the Company’s Advisory Board to assist the Company in evaluating potential opportunities in the biopharmaceutical area.

Modis Therapeutics announced today that Matthew R. Patterson, co-founder and Chief Executive Officer of Audentes Therapeutics, has joined Modis’ Board of Directors.

Kissei gains exclusive rights to fostamatinib in all current and potential indications in Japan and other Asian countries.

Mark Lipton, an attorney specializing in employee benefits, debated his Republican opponent October 18 at The Shell Factory in North Fort Myers.

Significant developments in cancer research were presented by NantHealth (NASDAQ: NH) and NantOmics at the ESMO conference in Munich, Germany this week.

Wireless platform enables unique OEM partnership opportunities for innovative device development in cardiovascular, respiratory, orthopedic, neurology and urodynamics applications.

Under the terms of the agreement, Bioasis to receive a US$1 million upfront payment from Prothena, plus additional potential option exercise, regulatory and commercial milestone payments, plus additional royalties on net sales from licensed products

Faith-Centered Non-Profit Organizations Partner to Provide Expanded Addiction Services for Patients Suffering with Substance Use Disorder

Leading, global professional organization goes live on-time, on-budget

In a joint, global position statement, the Society of Interventional Radiology (SIR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE) and the Interventional Radiology Society of Australasia (IRSA) have committed to providing necessary stroke training to interventional radiologists in order to alleviate the shortage of physicians trained in endovascular stroke therapies.